Eli Lilly and Company (LLY) is currently trading at $927.06. Based on 29 Wall Street analysts, the average target price is $1209.21, implying a 30.4% upside. The consensus recommendation is BUY.
LLY
Eli Lilly and Company
Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).
Price (USD)
Avg Target
$1209.21
Based on 29 analysts
Analyst Recommendations
Upside
+30.43%
Market Cap
$829.74B
Financial & Investment Metrics
Latest News
How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval
Lilly vs JPMorgan: Which Hits a $1 Trillion Market Cap First?
Eli Lilly’s Path to $1 Trillion Runs Directly Through the AI Boom
Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost Pipelines
2 Cash-Producing Stocks with Impressive Fundamentals and 1 We Brush Off
Insider Sentiment Index (Last 6 Months)
Buy vs Sell (Count)
Whale Trades (C-Level Large Buys)
No major insider buying detected recently.
Recent Insider Transactions
| Date | Name | Position | Transaction | Shares |
|---|---|---|---|---|
| 3/16/2026 | ALVAREZ RALPH | Director | Stock Award(Grant) at price 989.12 per share. | 12 |
| 3/16/2026 | FYRWALD J. ERIK | Director | Stock Award(Grant) at price 989.12 per share. | 10 |
| 3/16/2026 | SULZBERGER GABRIELLE | Director | Stock Award(Grant) at price 989.12 per share. | 5 |
| 3/16/2026 | LUCIANO JUAN R | Director | Stock Award(Grant) at price 989.12 per share. | 16 |
| 2/19/2026 | DOZIER ERIC | Officer | Stock Gift at price 0.00 per share. | 481 |
| 2/17/2026 | ALVAREZ RALPH | Director | Stock Award(Grant) at price 1036.05 per share. | 11 |
| 2/17/2026 | FYRWALD J. ERIK | Director | Stock Award(Grant) at price 1036.05 per share. | 9 |
| 2/17/2026 | SULZBERGER GABRIELLE | Director | Stock Award(Grant) at price 1036.05 per share. | 4 |
| 2/17/2026 | LUCIANO JUAN R | Director | Stock Award(Grant) at price 1036.05 per share. | 15 |
| 2/13/2026 | ZAKROWSKI DONALD A | Chief Financial Officer | N/A | 184 |
Frequently Asked Questions
Q. What is the current target price and upside for LLY?
A. The current target price for Eli Lilly and Company is $1209.21, which implies a 30.4% upside from the current price of $927.06. This is based on the consensus of 29 Wall Street analysts.
Q. What is the current analyst recommendation for LLY?
A. Currently, there are 6 Strong Buy, 18 Buy, 6 Hold, 1 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.
Q. Are insiders buying LLY stock recently?
A. Over the past 6 months, there have been 61 insider buys and 31 insider sells. This can be interpreted as a positive signal.